Wall Street slips heading into holiday
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group (UNH) Following 8-K Filing
December 26, 2017 7:55 AM ESTCantor Fitzgerald reiterated an Overweight rating and $235.00 price target on UnitedHealth Group (NYSE: UNH) following the company's 8-K filing. The filing indicates that the company has "signed a definitive purchase agreement and intends to launch a tender offer for Empresas Banmédica, an initial step toward... More
Celgene (CELG) PT Lowered to $130 at Stifel; 'Revlimid Plus Ritxuan did not Achieve Superiority with Co-Primary Endpoints'
December 22, 2017 8:18 AM ESTStifel lowered its price target on Celgene (NASDAQ: CELG) to $130.00 (from $149.00) while maintaining a Buy rating, following the company's announcement regarding an update of Phase 3 trial Revlimid (Revevance).
Analyst Thomas Shrader notes a cautious outlook on the shares, commenting "that Phase III trial... More
